Expansile nanoparticles (eNPs) use Materials‐Based Targeting to treat peritoneal cancers (e.g., mesothelioma, ovarian, pancreatic cancer).

Interactions with different molecules and native species in physiological or environmental surroundings, surface modifications, formation of biocorona, and artificial molecular loading for delivery, which can all be characterized and predicted using both experimental and computational tools.

Excellent biocompatibility, water dispersibility, and unique photoluminescence properties of carbon dots have made them a promising candidate for versatile biomedical applications at nanoscale.

Graphene oxide, the oxidized form of graphene, holds great potential as a scaffold for bone regeneration, deriving utility from its ability to support a broad range of chemical functionalities and an aqueous degradation pathway. This functionality can be tuned chemically to be biomimetic, and mechanically to be stiff yet strong.

Aptamer‐tethered DNA nanotrains used to transport drugs for theranostic applications as a freight train did for the goal of target‐specific therapeutic intervention.